21 results match your criteria: "Image-Guided Clinical Neuroscience and Connectomics[Affiliation]"

Trial of Lixisenatide in Early Parkinson's Disease.

N Engl J Med

April 2024

From the French Clinical Research Network (F-CRIN) for Parkinson's Disease and Movement Disorders (NS-Park-F-CRIN) (W.G.M., P.R., C. Giordana, D.M., P. Derkinderen, J.-L.H., M.A., I.B., T.B., C.B.-C., N.C., O.C., J.-C.C., P. Damier, E.D., D.D., S.D., M.F., V.F., A.F.-S., S.F.-K., S.G., C.H., L.H., P.K., B.L., R.L., L.-L.M., A.M., C.M., F.O.-M., H.S., C. Thiriez, M.T., O.R.), Centre d'Investigation Clinique (CIC) 1436 and the Departments of Clinical Pharmacology and Neurosciences, Centre Expert Parkinson, University Hospital of Toulouse, INSERM, University of Toulouse 3 (C.B.-C., H.C., M.F., F.O.-M., C. Thalamas, O.R.), and CIC 1436, INSERM (E.D., A.S.), Toulouse, Service de Neurologie des Maladies Neurodégénératives, Centre Expert Parkinson, Institut des Maladies Neurodégénératives (IMN) Clinique (W.G.M., T.B., A.F.-S., B.L.), and Service d'Information Médicale, Unité de Soutien Méthodologique à la Recherche (USMR) (A.G., C. Germain, A.B.), Centre Hospitalier Universitaire (CHU) Bordeaux, Unité Mixte de Recherche (UMR) 5293, Université de Bordeaux, Centre National de la Recherche Scientifique (CNRS), IMN, Unité Mixte de Recherche (UMR) 5293 (W.G.M., T.B., A.F.-S.), and the European Clinical Trials Platform and Development-F-CRIN, CIC-Clinical Epidemiology Unit 1401, University of Bordeaux, INSERM, Institut Bergonié, CHU Bordeaux (A.G., C. Germain, A.B.), Bordeaux, the Department of Neurology, Centre Expert Parkinson, Equipe 01-Neuropsychologie Interventionnelle L'Institut Mondor de Recherches Biomédicales, CHU Henri Mondor, INSERM et Faculté de Santé, Université Paris-Est Créteil, Créteil (P.R., H.S.), the Department of Neurology, Centre Expert Parkinson, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice (C. Giordana, V.F., C.M.), the Department of Neurology, Centre Expert Parkinson, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, UMR 1239, Rouen University Hospital, University of Rouen, INSERM, Mont-Saint-Aignan (D.M.), and the Department of Neurology, Centre Expert Parkinson, Rouen University Hospital and University of Rouen (C.H., R.L.), Rouen, the Department of Neurology, Centre Expert Parkinson, CIC 1413, CHU Nantes, INSERM, Nantes (P. Derkinderen, P. Damier), Service de Neurologie, Centre Expert Parkinson, CIC 1402, CHU Limoges, CHU Poitiers INSERM, Limoges (J.-L.H., I.B., O.C.), the Department of Neurology, Centre Expert Parkinson, Strasbourg University Hospital, and Strasbourg Federation of Translational Medicine, Strasbourg University, Strasbourg (M.A.), the Institute of Genetics and Cellular and Molecular Biology, INSERM Unité 964, CNRS-UMR 7104, University of Strasbourg, Illkirch-Graffenstaden (M.A.), the Department of Medical Pharmacology INSERM Unité 1172, Lille Neurosciences and Cognition, Centre Hospitalier Régional Universitaire, University of Lille, Lille (N.C., D.D.), the Department of Neurology, CIC Neurosciences, Sorbonne Université, Paris Brain Institute, Assistance Publique-Hôpitaux de Paris, INSERM, CNRS, Pitié-Salpêtrière Hospital, Paris (J.-C.C., L.-L.M.), the Department of Neurology, Centre Expert Parkinson, CIC 1414, CHU Pontchaillou de Rennes, INSERM, Rennes (S.D.), the Department of Neurology, Centre Expert Parkinson, CHU de Nancy, Hôpital Central, Nancy (S.F.-K., L.H.), the Department of Neurology, Centre Expert Parkinson, University Hospital La Timone, Marseille (S.G.), the Department of Neurology, Centre Expert Parkinson, University Hospital of Amiens, Amiens (P.K., M.T.), the Department of Neurology, CHU Clermont-Ferrand, Université Clermont-Auvergne, CNRS, Image Guided Clinical Neuroscience and Connectomics, Institut Pascal, Clermont-Ferrand (A.M.), the Department of Nutrition-Diabetology, CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac (V.R.), and the Department of Neurology, Centre Expert Parkinson, CHU de Caen, Caen (C. Thiriez) - all in France; the Department of Medicine, University of Otago, Christchurch, and the New Zealand Brain Research Institute - both in Christchurch, New Zealand (W.G.M.); Specialized Rehabilitation Hospital, Capital Health, Abu Dhabi, United Arab Emirates (P.K.); and Cure Parkinson's, London (S.R.W.S., R.K.W.).

Background: Lixisenatide, a glucagon-like peptide-1 receptor agonist used for the treatment of diabetes, has shown neuroprotective properties in a mouse model of Parkinson's disease.

Methods: In this phase 2, double-blind, randomized, placebo-controlled trial, we assessed the effect of lixisenatide on the progression of motor disability in persons with Parkinson's disease. Participants in whom Parkinson's disease was diagnosed less than 3 years earlier, who were receiving a stable dose of medications to treat symptoms, and who did not have motor complications were randomly assigned in a 1:1 ratio to daily subcutaneous lixisenatide or placebo for 12 months, followed by a 2-month washout period.

View Article and Find Full Text PDF

Purpose: Precise knowledge of the structural connectivity of white matter fascicles could yield new insights into function and is important for neurosurgical planning. Therefore, we aimed to provide a detailed map of the cortical terminations of the inferior fronto-occipital fascicle (IFOF), with special emphasis on putative inter-individual variations and hemispheric asymmetries.

Methods: Deterministic diffusion tensor imaging-based tractography was used to perform virtual dissection of the IFOF in 20 healthy subjects.

View Article and Find Full Text PDF

Investigation of antioxidant systems in human meibomian gland and conjunctival tissues.

Exp Eye Res

December 2017

GReD, Genetics, Reproduction & Development Laboratory, Université Clermont Auvergne, Clermont-Ferrand, France. Electronic address:

Oxidative stress (OS) associated with direct contact with the environment and light exposure is a very potent and continuous stressor of the ocular surface and internal structures of the eye that are required to manage its effects. Constant replenishment of tears together with the superficial lipid layer produced by the meibomian glands (MG) is one protective mechanism. The lipid-rich fraction of the tears coats the deeper aqueous fraction, preventing its evaporation.

View Article and Find Full Text PDF

fMRI study of graduated emotional charge for detection of covert activity using passive listening to narratives.

Neuroscience

May 2017

IGCNC (Image-Guided Clinical Neuroscience and Connectomics), Axe TGI (Thérapies guidées par l'image), Institut Pascal, Université Clermont Auvergne, Clermont-Ferrand, France; Service de Neurochirurgie, CHU Clermont-Ferrand, France.

Article Synopsis
  • The study investigates how functional neuroimaging, specifically fMRI, can help detect awareness in patients with consciousness disorders.
  • It outlines an fMRI protocol that examines brain responses to narratives with varying emotional content, hypothesizing that heightened emotional charge leads to distinct cerebral activations.
  • Results show that narratives connected to autobiographical memory consistently produce greater brain activation, emphasizing their importance in clinical assessments of consciousness.
View Article and Find Full Text PDF

Background: Deep brain stimulation (DBS) in Parkinson's disease uses bi-hemispheric high-frequency stimulation within the subthalamus, however, the specific impacts of bilaterality of DBS are still not clear. Thus, we aimed to study the individual-level clinical impact of locations of right-left contact pair-up accounting for each subthalamic nucleus (STN) anatomy.

Methods: Contact locations and effects at 1 year were studied retrospectively in an unselected series of 53 patients operated between 2004 and 2010.

View Article and Find Full Text PDF

OBJECTIVE Despite the widespread use of deep brain stimulation (DBS) for movement disorders such as Parkinson's disease (PD), the exact anatomical target responsible for the therapeutic effect is still a subject of research. Intraoperative stimulation tests by experts consist of performing passive movements of the patient's arm or wrist while the amplitude of the stimulation current is increased. At each position, the amplitude that best alleviates rigidity is identified.

View Article and Find Full Text PDF

Deep brain stimulation (DBS) surgery is extensively used in the treatment of movement disorders. Nevertheless, methods to evaluate the clinical response during intraoperative stimulation tests to identify the optimal position for the implantation of the chronic DBS lead remain subjective. In this paper, we describe a new, versatile method for quantitative intraoperative evaluation of improvement in tremor with an acceleration sensor that is mounted on the patient's wrist during surgery.

View Article and Find Full Text PDF

Personalized mapping of the deep brain with a white matter attenuated inversion recovery (WAIR) sequence at 1.5-tesla: Experience based on a series of 156 patients.

Neurochirurgie

August 2016

Image-guided clinical neuroscience and connectomics, Clermont université, université d'Auvergne, EA7282, 63000 Clermont-Ferrand, France; Service of neurosurgery, CHU Gabriel-Montpied, 58, rue Montalembert, 63003 Clermont-Ferrand, France. Electronic address:

Objective: Deep brain mapping has been proposed for direct targeting in stereotactic functional surgery, aiming to personalize electrode implantation according to individual MRI anatomy without atlas or statistical template. We report our clinical experience of direct targeting in a series of 156 patients operated on using a dedicated Inversion Recovery Turbo Spin Echo sequence at 1.5-tesla, called White Matter Attenuated Inversion Recovery (WAIR).

View Article and Find Full Text PDF

Despite a better understanding of brain language organization into large-scale cortical networks, the underlying white matter (WM) connectivity is still not mastered. Here we combined diffusion tensor imaging (DTI) fiber tracking (FT) and language functional magnetic resonance imaging (fMRI) in twenty healthy subjects to gain new insights into the macroscopic structural connectivity of language. Eight putative WM fascicles for language were probed using a deterministic DTI-FT technique: the arcuate fascicle (AF), superior longitudinal fascicle (SLF), uncinate fascicle (UF), temporo-occipital fascicle, inferior fronto-occipital fascicle (IFOF), middle longitudinal fascicle (MdLF), frontal aslant fascicle and operculopremotor fascicle.

View Article and Find Full Text PDF

Anti-NMDA-R encephalitis: Should we consider extreme delta brush as electrical status epilepticus?

Neurophysiol Clin

February 2016

Service de neurologie et unité de neurophysiologie clinique, CHU Gabriel-Montpied, 63000 Clermont-Ferrand, France; EA 7282, IGCNC (Image-Guided Clinical Neuroscience and Connectomics), UMR 6284 ISIT, UFR médecine, université d'Auvergne, 63000 Clermont-Ferrand, France.

Seizures are common clinical manifestations in anti-N-methyl-d-aspartate receptor (anti-NMDA-R) encephalitis, among other neurological and psychiatric symptoms. During the course of the disease, some specific EEG patterns have been described: generalized rhythmic delta activity (GRDA) and extreme delta brush (EDB). In comatose patients, the association of these EEG abnormalities with subtle motor manifestations can suggest ongoing non-convulsive status epilepticus (NCSE).

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to understand the motor development and brain changes in patients with PLP1-related disorders like Pelizaeus-Merzbacher disease and spastic paraplegia type 2, using MRI analysis over 7 years.
  • It followed 35 male patients of varying ages and categorized their motor function based on a scoring system, measuring brain areas, atrophy, and myelination.
  • Results indicated that patients with more severe motor impairments had greater brain atrophy and smaller corpus callosum areas, while myelination improved until age 12, highlighting the importance of brain changes in assessing motor development in these disorders.
View Article and Find Full Text PDF

Atypical clinical and radiological course of a patient with Canavan disease.

Metab Brain Dis

April 2016

Inserm U1141 Paris Diderot Sorbonne University - Paris Cité, DHU PROTECT, Robert Debré Hospital, Paris, France.

Canavan disease (CD) is a rare metabolic disorder caused by aspartoacylase (ASPA) deficiency. It leads to severe neurological degeneration with spongiform brain degeneration. Accumulation of N-acetylaspartate (NAA) in brain and urine is specific to the disease and guides diagnosis.

View Article and Find Full Text PDF

[Cluster headache treatment].

Presse Med

November 2015

Centre hospitalier universitaire de Nice, service de neurochirurgie, 06000 Nice, France; IGCN-EA 7282 (Image-Guided Clinical Neuroscience and Connectomics), UMR 6284 ISIT, UdA, 63000 Clermont-Ferrand, France.

Unlabelled: Acute treatment: sumatriptan, oxygen inhalation. Prophylactic treatment: verapamil, lithium carbonate. Transitional treatment.

View Article and Find Full Text PDF

Impact of localisation of deep brain stimulation electrodes on motor and neurobehavioural outcomes in Parkinson's disease.

J Neurol Neurosurg Psychiatry

July 2016

Univ Clermont 1, UFR Medecine, EA7280, Clermont-Ferrand, France Department of Psychiatry B, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Background: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) represents a well-established treatment in advanced Parkinson's disease (PD) for motor signs, but it is still debated concerning psychiatric effects.

Objective: Exploration of relation between position of active electrode contacts and neuropsychological and motor change after STN DBS procedure for PD.

Methods: A cohort of 34 patients who underwent STN DBS was followed for 6 months.

View Article and Find Full Text PDF

[Intra cranial meningiomas and long term use of cyproterone acetate with a conventional dose in women. A report of two cases of tumor decrease after treatment withdrawal].

Neurochirurgie

October 2015

EA 7282 IGCNC (Image-Guided Clinical Neuroscience and Connectomics) Clermont université, université d'Auvergne, UFR Médecine, 63000 Clermont-Ferrand, France; Service de neurochirurgie, hôpital Gabriel-Montpied, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand, France.

The action of synthetic progestogens, prescribed at a conventional dose in women, for a meningioma, is still poorly understood, and could be related to progesterone receptors. We report two cases illustrating multiple meningiomas with stabilization or tumor reduction after withdrawal of cyproterone acetate originally prescribed for a long term period. We also review the influence of synthetic progestogens on meningiomas, particularly the impact of treatment withdrawal.

View Article and Find Full Text PDF

Skull base morphology in fibroblast growth factor receptor type 2-related faciocraniosynostosis: a descriptive analysis.

Neurosurgery

May 2015

*Unité de Chirurgie Craniofaciale, Service de Neurochirurgie Pédiatrique, Centre de Référence National des Dysostoses Crâniofaciales, Hôpital Necker-Enfants Malades, APHP, Paris, France; ‡Service de Neurochirurgie, Hôpital Gabriel Montpied, Clermont-Ferrand, France; §Laboratoire d'anatomie, UFR Médecine, Universite[Combining Acute Accent] d'Auvergne, Clermont-Ferrand, France; ¶Image-Guided Clinical Neuroscience and Connectomics, EA 7282, UFR Médecine, Université Clermont 1, Universite d'Auvergne, Clermont-Ferrand, France; ‖Service de Biochimie et Biologie Moléculaire, Hôpital Lariboisière, APHP, Paris, France; #Département de Radiologie, Hôpital Necker-Enfants Malades, APHP, Paris, France.

Background: Children with faciocraniosynostosis present skull base abnormalities and may develop hydrocephalus or cerebellar tonsils ectopia (CTE). Several pathophysiological hypotheses were formulated in the past decades to explain these associations. However, no study has described in a genetically homogeneous population with confirmed fibroblast growth factor receptor type 2 (FGFR2) mutation eventual correlations between skull base abnormalities and hydrocephalus or CTE.

View Article and Find Full Text PDF

In mammals, the limited regenerating potential of the central nervous system (CNS) in adults contrasts with the plasticity of the embryonic and perinatal periods. SCO (subcommissural organ)-spondin is a protein secreted early by the developing central nervous system, potentially involved in the development of commissural fibers. SCO-spondin stimulates neuronal differentiation and neurite growth in vitro.

View Article and Find Full Text PDF

Electrical modulation of neuronal networks in brain-injured patients with disorders of consciousness: a systematic review.

Ann Fr Anesth Reanim

February 2014

IGCNC - EA 728, Image-Guided Clinical Neuroscience and Connectomics, université d'Auvergne, Clermont université, hôpital Gabriel Montpied, 2(e) étage, HC; 58, rue Montalembert, 63003 Clermont-Ferrand, France; Service de neurochirurgie, hôpital Gabriel-Montpied, CHU Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand, France.

Six clinical studies of chronic electrical modulation of deep brain circuits published between 1968 and 2010 have reported effects in 55 vegetative or minimally conscious patients. The rationale stimulation was to activate the cortex through the reticular-thalamic complex, comprising the tegmental ascending reticular activating system and its thalamic targets. The most frequent intended target was the central intralaminar zone and adjacent nuclei.

View Article and Find Full Text PDF

Maps of the adult human hypothalamus.

Surg Neurol Int

May 2013

Univ Clermont 1, UFR Médecine, EA 7282, Image-Guided Clinical Neuroscience and Connectomics, Clermont-Ferrand, F-63001, France ; Service de Neurochirurgie, CHU Clermont-Ferrand, Clermont-Ferrand, F-63003, France.

The human hypothalamus is a small deeply located region placed at the crossroad of neurovegetative, neuroendocrine, limbic, and optic systems. Although deep brain stimulation techniques have proven that it could be feasible to modulate these systems, targeting the hypothalamus and in particular specific nuclei and white bundles, is still challenging. Our goal was to make a synthesis of relevant topographical data of the human hypothalamus, under the form of magnetic resonance imaging maps useful for mastering its elaborated structure as well as its neighborhood.

View Article and Find Full Text PDF

Let live or let die after traumatic coma: Scrutinizing somatosensory evoked potentials.

Neurol Clin Pract

March 2012

Hospices Civils de Lyon (JL, LT), Hôpital Henry Gabrielle, Rééducation Neurologique, Lyon; INSERM, U1028 (JL), and CNRS, UMR5292 (JL), Lyon Neuroscience Research Center, IMPACT Team, Lyon; Université de Lyon (JL, FC, CF, NA-O), Université Lyon 1, Villeurbanne; Université de Lyon (FC), Université Lyon 1, Site Rockefeller, Laboratoire d'Anatomie, Lyon; Hospices Civils de Lyon (FC), Centre Hospitalier Lyon Sud, Service de Radiologie, Pierre Bénite; Université de Lyon (FC), Université Lyon 1, CREATIS-LRMN, CNRS UMR 5220, Lyon; INSERM U630 (FC), Villeurbanne; Centre Hospitalier Universitaire de Clermont-Ferrand (J-JL), Hôpital Gabriel Montpied, Service de Neurochirurgie, Clermont-Ferrand; Clermont Université (J-JL), Université d'Auvergne, IGCNC (Image-Guided Clinical Neuroscience and Connectomics), ISIT, Clermont-Ferrand; Hospices Civils de Lyon (JI), Service de Biostatistique, Lyon; INSERM, U1028 (CF), and CNRS, UMR5292 (CF), Lyon Neuroscience Research Center, Brain Dynamics and Cognition Team, Lyon; Hospices Civils de Lyon (CF, NA-O), Hôpital Neurologique Pierre Wertheimer, Neurologie Fonctionnelle, Bron; and Central Integration of Pain Lab (NA-O), Lyon Neuroscience Research Center, INSERM, U1028, CNRS, UMR5292, Bron, France.

It is now firmly established that bilateral abolition of somatosensory evoked potentials (SEPs) after a nontraumatic coma has 100% specificity for nonawakening. In traumatic coma, a bilateral absence of the N20 components of SEPs does not implicate nonawareness. Comatose brain-injured patients should be systematically explored with auditory evoked potentials to check the functional integrity of another sensory pathway and the mesencephalic tegmento-tectal region on cerebral MRI should be carefully examined.

View Article and Find Full Text PDF